Comprehensive Insights on Mosquito-borne Diseases Drug Development Pipeline Reviewed in New Research 2018


Published on : Jun 08, 2018

Albany, New York, June 8, 2018: More than half of the world’s population live in areas where this mosquito species are present. Mosquitoes are one of the poisonous animals in the world. Their ability to carry and spread the disease to humans causes millions of deaths every year. Therefore, a recent pipeline study, focusing on the drug development for mosquito-borne diseases has been broadcasted to the wide repository of Market Research Hub (MRH), which is titled as “Mosquito-borne Diseases Drug Development Pipeline Review, 2018”. The study discusses the past history, present status and future prospects of mosquito-borne disease drug development.

This report provides comprehensive information on the therapeutics under development primarily for West Nile virus infections, Japanese encephalitis, yellow fever and malaria. In the first part, the report presents an executive summary of the different type of mosquito-borne diseases along with its causes, symptoms and treatment methods. This subsequent section analyses the therapeutics pipeline through a comprehensive review, which is segmented by stage of development, mechanism of action, route of administration, molecule type and molecular target.

Key Highlights from the Study

In recent years, the rate of infection across the world has risen dramatically, and a growing number of scientists are now concerned that global warming will translate into an explosive growth of mosquito-borne diseases worldwide. Some of the major mosquito-borne diseases such as Malaria, dengue fever, yellow fever and West Nile virus are having potential that can lead to death. Malaria is a life-threatening blood disease. Their ability to carry and spread disease to humans causes millions of deaths every year. Symptoms may include fever, chills, headache, sweats, fatigue, enlarged spleen, nausea and vomiting. There are 206 products in development for this indication. The study also features dormant and discontinued products for each disease.

At present, some of the major molecular targets acted on by-products in development for mosquito-borne diseases include interferon receptors, toll-like receptors and pathogen proteins such as Plasmodium falciparum merozoite surface proteins.

Moreover, perspectives compiled in the report provides detailed insights on the leading market players operating in the mosquito-borne diseases drugs market. In-depth insights provided in this section of the report discusses the current market scenario and trends. Companies operating in this pipeline space include Sanaria, Medigen and Ology Bioservices.

Why invest in this report?

With all the precise information available in the study, the report audiences will understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication. The study also scrutinizes the institution and companies and universities presently functioning in the sector, as well as the product that are being handled by all of them.

Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1821757

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top